Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Suli Co., Ltd. (603585.SS)
Jiangyin, CN
Suli Co., Ltd., based in Jiangyin, China, operates as a chemical manufacturer engaged in the research, production, and sale of a diverse range of fine chemicals. Their product portfolio encompasses agrochemicals, flame retardants, and pharmaceutical intermediates. Within agrochemicals, the company provides technical-grade active ingredients like chlorothalonil, azoxystrobin, diflubenzuron, fluazinam, cymoxanil, and boscalid, along with various prepared pesticide formulations. For flame retardants, Suli produces decabromodiphenyl ethane, in addition to offering brominated, environmentally friendly, and halogen-free options. Their extensive list of chemical intermediates includes compounds such as trichloroacetonitrile, tetrachlorophthalonitrile, pentachloropyridine, pentachlorobenzonitrile, isophthalodinitrile, hydrobromic acid, 1,2-diphenylethane, and 1,2-dibromoethane. Furthermore, the company manufactures industrial biocides under the "Longee" brand, featuring products like 985CHL, 550CCD, 550CC, and 500CHL. They also supply a ferric chloride solution, primarily utilized for water treatment. These products, sold under the "Suli" brand, cater to a variety of industries, including agricultural production, plastics manufacturing, and building materials. Suli Co., Ltd. maintains a significant global presence, distributing its goods across the European Union, North America, South America, Africa, Southeast Asia, and other international markets.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.21% | -7.21% | -17.43% | -30.76% | -12.31% | -15.38% | +1.79% | +3.37% | +6.90% | -25.52% | -25.52% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+20.3% ★ Q1'26: -6.0% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+1,700.0% ★ Q1'26: -29.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+0.0% Q1'26: -8.6% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.1% ★ Q1'26: +7.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+6.3% ★ Q1'26: +3.0% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+11.0% Q1'26: -8.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×2.15× Q1'26: 8.40× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2018 actual |
Dec 2019 actual |
|---|---|---|
| Revenue |
1.65B
est: 1.66B (-0.6%)
|
1.81B
est: 1.97B (-8.0%)
|
| EBITDA |
566.42M
est: 266.08M (+112.9%)
|
537.60M
est: 316.60M (+69.8%)
|
| EBIT |
518.91M
est: 158.85M (+226.7%)
|
485.23M
est: 189.02M (+156.7%)
|
| Net Income |
312.10M
|
303.19M
|
| SGA |
94.84M
est: 26.94M (+252.1%)
|
109.82M
est: 32.05M (+242.6%)
|
| EPS |
1.73
|
1.68
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 2/5 | 2/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheng Chang | Deputy General Manager | — | male |
| Dawen Wang | Chief Engineer & Director | — | male |
| Gang Li | Chief Financial Officer & In Charge of Accounting Department | — | male |
| Hai Feng Sun | Deputy GM & Director | — | male |
| Jing Li Wang | Chairman & GM | — | female |
| Zhe Zhang | Board Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 603585.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
